Measures to prevent the risks associated with exposure to cytostatic drugs in glaucoma filtering surgery.

CONCLUSIONS: The prevention and awareness of the risks of the qualified professionals that handle these substances is the most important measure to prevent the possible risks. Coordination is necessary with the Occupational Health teams of the Hospital, as well as the professionals and staff involved in the different phases of the process, from the preparation in Hospital Pharmacy to its elimination. PMID: 32499062 [PubMed - as supplied by publisher]
Source: Archivos de la Sociedad Espanola de Oftalmologia - Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research

Related Links:

Condition:   Glaucoma Interventions:   Device: Baerveldt 350 implant;   Device: Ahmed ClearPath 350 implant Sponsor:   Duke University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
DISCUSSION: To the best of our knowledge, this is the first reported case of endocapsular haematoma as a complication of non-penetrating glaucoma surgery that has been successfully solved by a YAG capsulotomy. PMID: 32653318 [PubMed - as supplied by publisher]
Source: Archivos de la Sociedad Espanola de Oftalmologia - Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research
Publication date: 15 December 2020Source: Chemical Engineering Journal, Volume 402Author(s): Jui-Yang Lai, Li-Jyuan Luo, Duc Dung Nguyen
Source: Chemical Engineering Journal - Category: Chemistry Source Type: research
CONCLUSIONS: Cataract is the most critical complication in children with uveitis at presentation and raised intraocular pressure occurs at follow-up, perhaps attributed to the treatment. Maculopathy is the most common cause of blindness in these children. PMID: 32649841 [PubMed - as supplied by publisher]
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
Publication date: September 2020Source: Biomedical Signal Processing and Control, Volume 62Author(s): S.J. Grace Shoba, A. Brintha Therese
Source: Biomedical Signal Processing and Control - Category: Biomedical Science Source Type: research
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Glaucoma, Open-Angle Intervention:   Device: OMNI® Surgical System Sponsor:   Sight Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Glaucoma, Open-Angle Intervention:   Device: OMNI® Surgical System Sponsor:   Sight Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Glaucoma | Occupational Health | Opthalmology